Latest News

Keep up to date with all our latest investments, service offerings and news items.

Click here to view our latest media kit

• February 21, 2023

  Almac Group Awarded with Six CDMO Leadership Awards Across all Core Categories

• February 14, 2023

  Almac Pharma Services and Provention Bio, Inc Celebrate Rapid Launch of TZIELD™ (teplizumab-mzwv)

• January 23, 2023

  Almac Pharma Services Announces Two Vice President Appointments

• January 12, 2023

  Almac Pharma Services Recruiting Senior Operators in Charnwood

• December 13, 2022

  Almac Pharma Services Supports Rapid Launch of Provention Bio, Inc.’s Treatment TZIELD™ (teplizumab-mzwv)

• October 17, 2022

  Almac Pharma Services Supports Packaging and Supply of PTC Therapeutics’ Gene Therapy Upstaza™ for EU Launch

• October 4, 2022

  Almac Group Announces New COO and Appoints New Almac Pharma Services MD

• March 22, 2022

  Almac Group Clinical Supply and Commercial Solutions Support Agios’ Road to FDA Approval

• March 14, 2022

  Almac Pharma Services Expands its Unique Ultra-Low Temperature Solutions for Advanced Therapy Medicinal Products

• February 1, 2022

  Almac Group Recognised in Life Science Leader CMO Awards for the Eighth Time

• August 5, 2019

  Almac Group to Host EU Product Launch Workshop Series in California and Washington States

• March 26, 2019

  Almac Group Recognised with Six Life Science Leader CMO Awards

• October 2, 2018

  Almac Group Announces Successful HPRA Inspection at its European Campus

• July 25, 2018

  Almac Group Appoints Three Vice Presidents

• April 16, 2018

  Almac Group Expands US Specialised Commercial Packaging Capabilities

• January 18, 2018

  Almac Group announces further expansion at its European Campus in Dundalk

• October 23, 2017

  Almac Group Announces Successful MHRA Inspection at Charnwood Facilities

• June 30, 2017

  Petya ransomware attack – Almac update

• March 15, 2017

  Almac to Exclusively Share Global Expertise in EU Product Launch Workshop

• November 14, 2016

  Almac Group Expands Commercial Capabilities to Meet Industry Demand for Paediatric Formulations

• August 2, 2016

  Almac Group’s Integrated Development to Commercialisation Services Support Amicus Therapeutics’ First Commercial Orphan Drug Product

• July 14, 2016

  Almac Group’s Rapid Launch Services Support U.S. Approval of Intercept Pharmaceutical’s First Commercial Orphan Drug Product

• April 25, 2016

  Almac Group Launches US Serialisation Solution in Partnership with Optel Vision

• March 23, 2016

  Almac Wins Three CMO Leadership Awards

• October 7, 2015

  Almac Group Addresses Industry Demand for Multiparticulate Drug Products with Scalable Fluid Bed and Encapsulation Technologies

• September 9, 2015

  Almac Group’s Integrated CMC Services Support US Approval of Wellstat Therapeutics’ First Commercial Orphan Drug Product

• November 18, 2013

  Almac Further Enhance 3rd Party Logistics Commercial Support Services for Niche / Orphan Drugs

• February 6, 2013

  Almac launches US commercial packaging operations with successful FDA inspection and new client partnership

• October 3, 2012

  Almac expands UK commercial capacity with the acquisition of new blistering technology

• May 1, 2012

  Almac installs Uhlmann Blister Line in new US Commercial Packaging Facility

• March 7, 2012

  Almac expands in US with addition of Commercial Packaging facility in Audubon

• February 28, 2012

  Almac Boosts Capacity and Productivity with Acquisition of New Encapsulation Equipment

• November 21, 2011

  Almac Responds to Alexion’s Request for Rapid Packaging and Distribution During Public Health Crisis in Germany

• March 25, 2011

  Almac announces expansion to its commercial facility with the addition of increased storage capacity for biologic products

• November 26, 2010

  Almac adds Late Stage Customisation Suite to assist Orphan Drug / Niche Product Launches into Europe

• June 14, 2010

  Almac completes £2 million client sponsored investment expanding commercial sacheting capacity

• April 19, 2010

  Almac completes its expansion plan to Pharma Services facilities

• October 15, 2009

  Almac Announce Potent Containment Capabilities

• October 14, 2009

  Almac Extends Commercial Support Services to add Third Party Logistics “3PL”

• June 30, 2009

  Almac Completes Phase 1 of its Expansion Plan to Pharma Services Facilities

• June 2, 2009

  Almac and Middlebrook Pharmaceuticals discuss their successful partnership in Tablets and Capsules

• February 5, 2009

  Almac Pharma Services Retained by MiddleBrook Pharmaceuticals to Produce Physician Samples of MOXATAG

• March 20, 2008

  Almac Pharma Services Expands it Commercial Support Capability

• March 17, 2008

  Almac appoints new VP Commercial Operations for Pharma Services